American Trust Bristol Myers Squibb CO Transaction History

American Trust

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $15,991 - $17,755	-251 Reduced 3.31%	7,337 $469,000
Q1 2023 May 22, 2023	BUY	$65.71 - $74.53 $2,299 - $2,608	35 Added 0.46%	7,588 $525,000
Q4 2022 Feb 16, 2023	SELL	$68.48 - $81.09 $8,628 - $10,217	-126 Reduced 1.64%	7,553 $543,000
Q3 2022 Dec 02, 2022	SELL	$0.13 - $76.84 $29 - $17,673	-230 Reduced 2.91%	7,679 $546,000
Q2 2022 Oct 03, 2022	BUY	$72.62 - $79.98 $209,145 - $230,342	2,880 Added 57.27%	7,909 $609,000
Q1 2022 Jun 08, 2022	BUY	$61.48 - $73.72 $309,182 - $370,737	5,029 New	5,029 $368,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

Stay updated on American Trust with notifications on news.